ATE295727T1 - Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen - Google Patents

Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen

Info

Publication number
ATE295727T1
ATE295727T1 AT02730033T AT02730033T ATE295727T1 AT E295727 T1 ATE295727 T1 AT E295727T1 AT 02730033 T AT02730033 T AT 02730033T AT 02730033 T AT02730033 T AT 02730033T AT E295727 T1 ATE295727 T1 AT E295727T1
Authority
AT
Austria
Prior art keywords
treatment
diseases
viral
piracetam
certain substituted
Prior art date
Application number
AT02730033T
Other languages
English (en)
Inventor
Jacques Peuvot
Robert Brasseur
Michel Deleers
Fausto A Pontes
Jean-Marie Ruysschaert
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of ATE295727T1 publication Critical patent/ATE295727T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
AT02730033T 2001-03-22 2002-03-20 Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen ATE295727T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01107140 2001-03-22
PCT/EP2002/003106 WO2002076451A1 (en) 2001-03-22 2002-03-20 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases

Publications (1)

Publication Number Publication Date
ATE295727T1 true ATE295727T1 (de) 2005-06-15

Family

ID=8176886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02730033T ATE295727T1 (de) 2001-03-22 2002-03-20 Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen

Country Status (6)

Country Link
US (1) US20040092575A1 (de)
EP (1) EP1392290B1 (de)
AT (1) ATE295727T1 (de)
DE (1) DE60204224T2 (de)
ES (1) ES2242024T3 (de)
WO (1) WO2002076451A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019247A2 (en) * 2003-08-15 2005-03-03 Board Of Regents, The University Of Texas System Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
WO2005028435A1 (en) * 2003-09-24 2005-03-31 Ucb, S.A. Process for preparing 2-oxo-1-pyrrolidine derivatives
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
US7157421B2 (en) 2004-12-27 2007-01-02 Miller Landon C G Piracetam and piracetam analog conjugate and a pharmaceutical composition for treatment of neuronal disorders
AU2006274263B2 (en) * 2005-07-26 2011-01-27 Ucb Pharma, S.A. Pharmaceutical compositions comprising levetiracetam and process for their preparation
US20080014264A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
US8940730B2 (en) 2007-09-18 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions of treating a Flaviviridae family viral infection
US9149463B2 (en) * 2007-09-18 2015-10-06 The Board Of Trustees Of The Leland Standford Junior University Methods and compositions of treating a Flaviviridae family viral infection
JP5715820B2 (ja) * 2007-09-18 2015-05-13 スタンフォード ユニバーシティー フラビウイルス科ファミリーのウイルスへの感染を治療する方法ならびに、フラビウイルス科ファミリーのウイルスへの感染を治療するための組成物
US9101628B2 (en) * 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
EP2408449A4 (de) 2009-03-18 2012-08-08 Univ Leland Stanford Junior Verfahren und zusammensetzungen zur behandlung von flaviviridae-virusinfektionen
CN103073477A (zh) * 2013-01-24 2013-05-01 吉林三善恩科技开发有限公司 以3,4-二羟基苯甲酸为前驱体的吡拉西坦药物共晶及其制备方法
CN103044306A (zh) * 2013-01-24 2013-04-17 吉林化工学院 一种新型吡拉西坦药物共晶及其制备方法
DE102021003961A1 (de) 2021-07-29 2023-02-02 CARMFI Holding AG Verfahren zur Herstellung wässriger Arzneimittellösungen mit unterschiedlichen Zusammensetzungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition

Also Published As

Publication number Publication date
ES2242024T3 (es) 2005-11-01
DE60204224T2 (de) 2006-02-02
WO2002076451A1 (en) 2002-10-03
EP1392290B1 (de) 2005-05-18
EP1392290A1 (de) 2004-03-03
US20040092575A1 (en) 2004-05-13
DE60204224D1 (de) 2005-06-23

Similar Documents

Publication Publication Date Title
ATE295727T1 (de) Verwendung bestimmter substituierter pyrrolidone wie z.b. piracetam bei der behandlung von viralen und anderen erkrankungen
ATE508635T1 (de) Virusvektoren und ihre verwendung bei therapeutischen methoden
HUS1700003I1 (hu) Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
BG108660A (en) Pyrrolidinone derivatives
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
WO2002062961A3 (en) Peptide scaffold encapsulation of tissue cells and uses thereof
MXPA02006679A (es) Composicion farmaceutica.
ATE358669T1 (de) Pyrazolderivate zur behandlung von hiv
ATE335748T1 (de) Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
EP1322307A4 (de) Verfahren zur behandlung von zellproliferationen störungen und virusinfektionen
ATE383424T1 (de) Polypeptide, deren herstellung und verwendung
ATE420097T1 (de) Substituierte sapogenine und ihre verwendung
EP1461079A4 (de) Mutanten von hüllglykoproteinen des human immunodeficiency virus und deren verwendung
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
WO2001010456A3 (en) Peptides that block viral infectivity and methods of use thereof
DE69825625D1 (de) Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
CA2531419C (fr) Procede de stabilisation d'un cryoprecipite de proteines plasmatiques destine a etre soumis a un traitement thermique d'inactivation virale
ATE374208T1 (de) Pharmakologisch aktive antivirale peptide und methoden zu ihrer anwendung
WO2001043693A3 (en) Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
TR199901385T2 (xx) Piperidin t�revleri.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties